3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
20
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Conditions
Lung Neoplasms
65
Carcinoma, Non-Small-Cell Lung
46
Neoplasms
9
Breast Neoplasms
9
Melanoma
7
Head and Neck Neoplasms
7
Ovarian Neoplasms
6
Colorectal Neoplasms
5
Small Cell Lung Carcinoma
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Pancreatic Neoplasms
3
Neoplastic Cells, Circulating
3
Neoplasm Metastasis
3
Mesothelioma
3
Kidney Neoplasms
3
Esophageal Neoplasms
3
Stomach Neoplasms
2
Sarcoma
2
Plaque, Atherosclerotic
2
Liver Neoplasms
2
Endometrial Neoplasms
2
Disease
2
Colonic Neoplasms
2
Bronchitis, Chronic
2
Adenocarcinoma
2
Vulvar Neoplasms
1
Uterine Neoplasms
1
Urologic Neoplasms
1
Thyroid Neoplasms
1
Interventions
pembrolizumab
24
Nivolumab
19
atezolizumab
9
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Cyclophosphamide
7
durvalumab
5
Ipilimumab
5
fludarabine
4
Trastuzumab
4
cemiplimab
3
cabozantinib
3
avelumab
3
Sunitinib
3
Biopsy
3
ulixertinib
2
toripalimab
2
tislelizumab
2
spartalizumab
2
sargramostim
2
relatlimab
2
palbociclib
2
lenvatinib
2
epacadostat
2
enzalutamide
2
cyclopropapyrroloindole
2
copanlisib
2
budigalimab
2
aldesleukin
2
X-Rays
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Blood Specimen Collection
×
Thoracic
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled